Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.

NCT01715233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Esophageal Cancer
Gastroesophageal Cancer
Gastric Cancer

Interventions

DRUG: Docetaxel
DRUG: Leucovorin
DRUG: Fluorouracil
DRUG: Cisplatin

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins